Results for intraperitoneally translation from English to Maltese

(bb) the tuberculin is injected intraperitoneally into two guinea-pigs.
(bb) it-tuberkulin hu injettat intraperitonealment fiż-żewġt ifniek ta' l-indja.

removab must not be administered as a bolus or by any route other than intraperitoneally.
removab m’għandux jingħata bħala bolus jew minn xi post ieħor ħlief minn ġol-peritonew.

leflunomide, administered orally and intraperitoneally, has been studied in acute toxicity studies in mice and rats.
leflunomide, li ngħata oralment u fil-kavita tal-peritonew, kien studjat mill-aspett ta’ tossiċità akuta fil-ġrieden u l-firien.

728 patients received catumaxomab intraperitoneally, 293 patients as 6 hour - and 435 patients as 3 hour infusions.
728 pazjent irċivew catumaxomab ġol-peritonew, 293 pazjent bħala infużjoni ta’ 6 sigħat - u 435 pazjent bħala infużjoni ta’ 3 sigħat.

inject intraperitoneally along the central line, 1/2 to 1 fin length in front of the pelvic fin base.
injetta intraperitonjalment matul il-linja ċentrali, daqs nofs jew tul ta’ ġewnaħ (tal-ħuta) quddiem il- post ma fejn hu mwaħħal il-ġewnaħ tan-naħa tal-pelvis.

removab must be administered intraperitoneally over an infusion time of at least 3 hours via a constant infusion pump system as described below:
removab għandu jingħata ġol-peritonew fuq ħin ta’ infużjoni ta’ mill-inqas 3 sigħat permezz ta’ sistema ta’ pompa għal infużjoni kostanti kif deskritt hawn taħt:

one ld50 unit corresponds to the median lethal dose (ld50) when the reconstituted product is injected intraperitoneally into mice under defined conditions.
unità waħda ta ’ ld50 tikkorrispondi għall- medjan tad- doża letali (ld50) meta l- prodott rikostitwit ikun injettat b’ mod intraperitoneali fil- ġrieden taħt kundizzjonijiet definiti.

an increased incidence of tumours in the lymphoreticular system, lung, mammary gland, and skin was seen in mice treated with azacitidine administered intraperitoneally for 50 weeks.
kienet osservata żieda fl-inċidenza ta’ tumuri fis- sistema limforetikulari, fil-pulmun, fil-glandola mammarja, u fil-ġilda fil-ġrieden ikkurati b’azacitidine mogħti mill-peritonew għal 50 ġimgħa.

in another study, rats also received the same semi-synthetic insulin via an intraperitoneally implanted osmotic mini-pump infusion for up to 6 weeks.
fi studju ieħor, il-firien irċivew ukoll l-istess insulina semisintetika umana permezz ta’ infużjoni minn pompa żgħira impjantata fil- peritonew sa 6 ġimgħat.

no immunogenic response was detected in a 12-week study in mice in which pegaspargase was weekly administered at the dose of 10.5 u/mouse intramuscular or intraperitoneally.
ma ġie osservat l-ebda rispons immunoġeniku fi studju fil-ġrieden li dam 12-il ġimgħa li fih pegaspargase ingħata kull ġimgħa fid-doża ta' 10.5 u/ġurdien ġol-muskoli jew ġol-peritonew.

prior to sacrifice, animals are injected intraperitoneally with an appropriate dose of a metaphase arresting agent (e.g. colcemid® or colchicine).
qabel is-sagrifiċċju, l-annimali huma injettati intraperitonalment b'doża xierqa ta' aġent li jwaqqaf l-metafażi (eż. colcemid® jew kolċiċina).

only very high doses of pegaspargase given to mice intraperitoneally as a single dose (25000 – 100000 u/kg body weight) caused the death of 14% of all treated mice.
dożi għoljin ħafna biss ta' pegaspargase mogħtija lill-ġrieden minn ġol-peritonew (i.p.) bħala doża waħda (25000 – 100000 u/kg ta' piż tal-ġisem) ikkawżaw il-mewt ta' 14% tal-ġrieden kollha kkurati.